Class Action Lawsuit Filed Against Immutep Limited (NASDAQ: IMMP) Over Alleged Securities Fraud
A class action lawsuit has been filed against Immutep Limited (NASDAQ: IMMP) and certain officers and directors, alleging securities fraud. The lawsuit follows the company's announcement on March 13, 2026, that an independent committee recommended discontinuing a key clinical trial, leading to an 82.44% drop in the stock price.
Tickers: $IMMP
Topics: class action clinical trial discontinuation securities fraud stock price drop